MORGANTOWN, W.Va. (WDTV) -- The WVU Stroke Center at J.W. Ruby Memorial Hospital has earned The Joint Commission’s Gold Seal of Approval and the American Heart Association/American Stroke Association’s Heart-Check mark for Advanced Certification for Comprehensive Stroke Centers, WVU Medicine announced Thursday.
This gives the stroke center the only advanced certification for comprehensive stroke centers in West Virginia.
Both the certification and other recognition are given for the hospital’s work in focusing on specialized stroke care. Officials say that to be eligible for the Joint Commission Comprehensive Stroke Center certification, a hospital must “demonstrate compliance with stroke-related standards as a Primary Stroke Center and meet additional requirements, including those related to advanced imaging capabilities, 24/7 availability of specialized treatments, and providing staff with the unique education and competencies to care for complex stroke patients.”
“The WVU Stroke Center underwent a rigorous onsite review, during which Joint Commission experts evaluated compliance with stroke-related standards and requirements,” officials say.
The Advanced Certification for Comprehensive Stroke Centers is awarded to Joint Commission-accredited acute care hospitals a two-year period.
“The certification was derived from the Brain Attack Coalition’s “Recommendations for Comprehensive Stroke Centers” (“Stroke,” 2005), “Metrics for Measuring Quality of Care in Comprehensive Stroke Centers” (“Stroke,” 2011), and recommendations from a multidisciplinary advisory panel of experts in complex stroke care. It is the highest of three stroke designations certified by the Joint Commission,” officials say.
The stroke center has also been consistently recognized with the American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Gold Plus Achievement Award with Target: StrokeSM Honor Roll Elite Plus quality-improvement program.
“Target: Stroke Honor Roll Elite Plus recognizes hospitals that reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA. A short “door-to-needle” time is imperative to preserve brain function after a stroke,” officials say.